Received Jun 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
still to this day have a pain where the shot was administered; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A 71-year-old patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 01Apr2025 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Comirnaty (Primary immunization series complete), for Covid-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 2025, outcome "unknown", described as "still to this day have a pain where the shot was administered". The event "still to this day have a pain where the shot was administered" required physician office visit. Additional information: The patient went to the Doctor and it could be two things, a reaction to drug or the pharmacist hit a nerve. The patient stated that all his/her COVID shots where Pfizer and until now have had no issues. The information on the batch/lot number for BNT162b2 omicron (kp.2) will be requested and submitted if and when received.